PKM and neoplasm: Consistent with these findings, TEPP-mediated activation of PKM2 in a murine solid CT26 tumor model reduced the ability of macrophages, dendritic cells, T cells, and tumor cells to express programmed death-1 (PD-1) ligand 1 (PD-L1) [179] (Figure 2).